ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 980,18
0,06%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Unum Therapeutics Inc (UMRX)

  7. Unum Therapeutics Inc (UMRX) Actualités

UMRX

Unum Therapeutics (UMRX)

Unum Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:UMRX
DateHeureSourceTitreSymboleSociété
13/06/202322h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:UMRXUnum Therapeutics Inc
13/06/202322h07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:UMRXUnum Therapeutics Inc
08/06/202322h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:UMRXUnum Therapeutics Inc
08/06/202322h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:UMRXUnum Therapeutics Inc
01/06/202323h01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:UMRXUnum Therapeutics Inc
09/05/202314h23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:UMRXUnum Therapeutics Inc
25/04/202322h11Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:UMRXUnum Therapeutics Inc
25/04/202322h07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:UMRXUnum Therapeutics Inc
14/03/202321h03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:UMRXUnum Therapeutics Inc
14/03/202314h08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:UMRXUnum Therapeutics Inc
14/02/202323h18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:UMRXUnum Therapeutics Inc
10/02/202322h58Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:UMRXUnum Therapeutics Inc
06/05/202223h26Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:UMRXUnum Therapeutics Inc
06/05/202222h34Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:UMRXUnum Therapeutics Inc
26/04/202214h28Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:UMRXUnum Therapeutics Inc
09/02/202213h00GlobeNewswire Inc.Cogent Biosciences to Present at 11th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:UMRXUnum Therapeutics Inc
05/05/202122h32Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:UMRXUnum Therapeutics Inc
31/03/202116h17Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:UMRXUnum Therapeutics Inc
19/03/202111h06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:UMRXUnum Therapeutics Inc
02/12/202012h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:UMRXUnum Therapeutics Inc
06/10/202023h29Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:UMRXUnum Therapeutics Inc
06/10/202022h42Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:UMRXUnum Therapeutics Inc
05/10/202014h58PR Newswire (US)Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational ProgressNASDAQ:UMRXUnum Therapeutics Inc
31/08/202013h30GlobeNewswire Inc.SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum TherapeuticsNASDAQ:UMRXUnum Therapeutics Inc
31/08/202013h30PR Newswire (US)Unum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIONASDAQ:UMRXUnum Therapeutics Inc
11/08/202023h00PR Newswire (US)Unum Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate UpdatesNASDAQ:UMRXUnum Therapeutics Inc
30/07/202014h04Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:UMRXUnum Therapeutics Inc
10/07/202012h00Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:UMRXUnum Therapeutics Inc
06/07/202016h16PR Newswire (US)Unum Therapeutics Inc. Announces Acquisition of Kiq LLCNASDAQ:UMRXUnum Therapeutics Inc
11/05/202023h12Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:UMRXUnum Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:UMRX

Dernières Valeurs Consultées

BIT
UB4Q79
Unicredit Bank
CSE
BLVD
BLVD Centers Corporation
COIN
MDEXUSD
NYSE
CNB
Colonial Bancgroup
ASX
APAKOP
TSX
MBAL
Mackenzie Balanced Alloc...
DOWI
DJUSWCT
DJ US Mobile Telecommuni...
BIT
F19036
Vontobel Financial Produ...
LSE
SC09
Citi Grp.25
UNSW3
SWKETH
Sowaka
BIT
IWQU
Exchange Traded
NASDAQ
ABBBDXX
Hsbc Bank Usa Na Capped ...
NYSE
BRK.B
Berkshire Hathaway
COIN
TRXCETH
TronClassic
USOTC
HSSKF
Huber and Suhner (PK)
COIN
TGTGBP
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés